First Drug Approved for Familial Chylomicronemia Syndrome

(MedPage Today) -- The FDA approved olezarsen (Tryngolza) as the first drug for adults with familial chylomicronemia syndrome, a rare genetic disorder that can cause triglyceride levels to reach the thousands.
A first-in-class antisense oligonucleotide...